A Study of Entinostat and FOLFOX in Subjects With Pancreatic Adenocarcinoma
Clinical trial NCT03760614 · WITHDRAWN
Trial details
- NCT number
- NCT03760614
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2022-07-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.